Cargando…
Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study
Currently, little in-depth evidence is known about the application of extracorporeal membrane oxygenation (ECMO) therapy in coronavirus disease 2019 (COVID-19) patients. This retrospective multicenter cohort study included patients with COVID-19 at 7 designated hospitals in Wuhan, China. The patient...
Autores principales: | Fang, Jing, Li, Rui, Chen, Yue, Qin, Juan-juan, Hu, Ming, Huang, Chao-lin, Cheng, Lin, He, Yi, Li, Yi, Zhou, Qiang, Zhou, Dai-xing, Huang, Fei, Lei, Fang, Yang, Bo, Chen, Jun, Deng, Hong-ping, Yuan, Yu-feng, Xia, Jia-hong, Wan, Song, Li, Hong-liang, Wei, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Huazhong University of Science and Technology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881911/ https://www.ncbi.nlm.nih.gov/pubmed/33582899 http://dx.doi.org/10.1007/s11596-021-2311-8 |
Ejemplares similares
-
Retrospective Study of Critically Ill COVID-19 Patients With and Without Extracorporeal Membrane Oxygenation Support in Wuhan, China
por: Cheng, Wei, et al.
Publicado: (2021) -
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019
por: Byun, Joung Hun, et al.
Publicado: (2020) -
Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review
por: Pleșoianu, Alexandru Florin, et al.
Publicado: (2021) -
Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021) -
A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
por: Qiu, Liru, et al.
Publicado: (2020)